Problems.
- pushed by Giuliani and Trump not the Fda
- not proved safety
- umbilical killer cells might trigger immune response, exact opposite to quelling the storm. So might end up killing patients
- no compassionate use granted
- initial trial 60 days will then need placebo trial after - another 3- 4 months. 6 months, then will need to apply to fda
- meso milder dose is proving more effective than other treatments
Conclusion - shot in the dark.
Ann: US NIH Trials Network to Conduct COVID-19 Phase 2/3 Trial, page-210
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23940 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 22571 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |